rociletinib
Showing 1 - 7 of 7
Locally Advanced or Metastatic Non Small Cell Lung Cancer Trial in Worldwide (Rociletinib)
Terminated
- Locally Advanced or Metastatic Non Small Cell Lung Cancer
- Rociletinib
-
Duarte, California
- +48 more
Jul 26, 2020
NSCLC Trial in Santa Monica (Rociletinib, MPDL3280A)
Terminated
- Non-small Cell Lung Cancer
- Rociletinib
- MPDL3280A
-
Santa Monica, CaliforniaUniversity of California at Los Angeles
Jun 28, 2019
NSCLC Trial in Worldwide (Rociletinib)
Terminated
- Non-small Cell Lung Cancer
- Rociletinib
-
Alhambra, California
- +90 more
Jul 28, 2020
NSCLC Trial in United States (Rociletinib, Trametinib)
Terminated
- Non-small Cell Lung Cancer
- Rociletinib
- Trametinib
-
Saint Louis, Missouri
- +3 more
Sep 28, 2018
NSCLC Trial in United States (Rociletinib)
No longer available
- Non-small Cell Lung Cancer
- Rociletinib
-
Scottsdale, Arizona
- +10 more
Sep 24, 2018
NSCLC Trial in Worldwide (Rociletinib, Pemetrexed or gemcitabine or paclitaxel or docetaxel)
Terminated
- Non-small Cell Lung Cancer
- Rociletinib
- Pemetrexed or gemcitabine or paclitaxel or docetaxel
-
Bakersfield, California
- +79 more
Jul 31, 2019
NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial (Rociletinib, Biopsy, Blood draw)
Withdrawn
- Carcinoma, Non-Small-Cell Lung
- +2 more
- Rociletinib
- +2 more
- (no location specified)
May 16, 2016